Cleared Traditional

K910520 - SAFETYSNAP SAFETY SYRINGE

K910520 is an FDA 510(k) clearance for SAFETYSNAP SAFETY SYRINGE, manufactured by U.S. Medical Instruments, Inc.. The device is a Class 2 General Hospital device with product code FMF cleared through the Traditional 510(k) pathway after a 69-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1991
Decision
69d
Days
Class 2
Risk

K910520 is an FDA 510(k) clearance for the SAFETYSNAP SAFETY SYRINGE. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by U.S. Medical Instruments, Inc. (La Jolla, US). The FDA issued a Cleared decision on April 16, 1991 after a review of 69 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K910520

510(k) Number K910520 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 06, 1991
Decision Date April 16, 1991
Days to Decision 69 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
60d faster than avg
Panel avg: 129d · This submission: 69d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 755
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K910520.
CELSITE(TM) IMPLANTABLE DRUG DELIVERY SYSTEM
K902401 · Burron Medical, Inc. · Oct 1991
MODIFIED VERSION IMPLANTABLE VASCULAR ACCESS SYSTE
K912111 · Gerard Medical Enterprises, Inc. · Oct 1991
DISPOSABLE RETRACTABLE NEEDLE SYRINGE
K910731 · Safe Tech Medical Products, Inc. · May 1991
DAVID SIMMONDS ANESTHESIA EXTENSION TUBES
K905384 · Sparta Surgical Corp. · Mar 1991
STERAID DISPOSABLE SYRINGE
K904620 · Disposable Medi-Aids , Ltd. · Mar 1991
YUEFA DISPOSABLE SYRINGE
K902178 · Blue & Red Corp. · Dec 1990